NCT01160380 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 25
- group Id
- BG001
- value
- 25
- group Id
- BG002
- value
- 50
- units
- Participants
- groups
- description
- The patients receive armodafinil for all 56 days of the study. armodafinil: Armodafinil taken at 150 mg daily. Taken as three 50 mg tablets.
- id
- BG000
- title
- Armodafinil
- description
- These patients receive a placebo for the first 28 days of the study. They are then crossed over and receive armodafinil for the final 28 days of the study (days 29-56). armodafinil: Armodafinil taken at 150 mg daily. Taken as three 50 mg tablets. Placebo: Placebo taken at 150 mg daily. Taken orally as three 50 mg tablets.
- id
- BG001
- title
- Placebo-First
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 1.8
- value
- 63
- group Id
- BG001
- spread
- 2.3
- value
- 67
- group Id
- BG002
- spread
- 2.1
- value
- 65
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 14
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 29
- title
- Female
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 21
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 8
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 37
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 12
- title
- 0
- categories
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 35
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- title
- 2
- description
- Grade ECOG Performance status 0 Fully active, performance without restriction 1. Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work 2. Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours 3. Capable of only limited self-care, confined to bed or chair more than 50% of waking hours 4. Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair 5. Dead
- param Type
- NUMBER
- title
- ECOG (Eastern Cooperative Oncology Group)
- unit Of Measure
- paarticipants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 39
- upper Limit
- 83
- value
- 59
- group Id
- BG001
- lower Limit
- 36
- upper Limit
- 79
- value
- 60.5
- group Id
- BG002
- lower Limit
- 36
- upper Limit
- 83
- value
- 60
- description
- BFI scale: 9 items; range=0-90 (0-10 per item) Mild = 1-3 Moderate = 4-7 Severe = 8-10
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Fatigue (baseline)-Brief Fatigue Inventory (BFI)
- unit Of Measure
- units on a scale
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 6
- upper Limit
- 12
- value
- 9
- group Id
- BG001
- lower Limit
- 6
- upper Limit
- 12
- value
- 9
- group Id
- BG002
- lower Limit
- 6
- upper Limit
- 12
- value
- 9
- description
- ICD-10 Criteria (Range: 0-14) A1-A11 Fatigue Criteria B. Clinically significant distress or impaired functioning C. Symptoms are a consequence of cancer or cancer therapy D. Symptoms are a consequence of comorbid psychiatric disorders
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Fatigue (baseline)-International Classification of Diseases version 10 (ICD-10)
- unit Of Measure
- units on a scale
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 25
- group Id
- BG001
- value
- 25
- group Id
- BG002
- value
- 50
- units
- Participants
- groups
- description
- The patients receive armodafinil for all 56 days of the study. armodafinil: Armodafinil taken at 150 mg daily. Taken as three 50 mg tablets.
- id
- BG000
- title
- Armodafinil
- description
- These patients receive a placebo for the first 28 days of the study. They are then crossed over and receive armodafinil for the final 28 days of the study (days 29-56). armodafinil: Armodafinil taken at 150 mg daily. Taken as three 50 mg tablets. Placebo: Placebo taken at 150 mg daily. Taken orally as three 50 mg tablets.
- id
- BG001
- title
- Placebo-First
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 1.8
- value
- 63
- group Id
- BG001
- spread
- 2.3
- value
- 67
- group Id
- BG002
- spread
- 2.1
- value
- 65
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 14
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 29
- title
- Female
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 21
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 8
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 37
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 12
- title
- 0
- categories
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 35
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- title
- 2
- description
- Grade ECOG Performance status 0 Fully active, performance without restriction 1. Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work 2. Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours 3. Capable of only limited self-care, confined to bed or chair more than 50% of waking hours 4. Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair 5. Dead
- param Type
- NUMBER
- title
- ECOG (Eastern Cooperative Oncology Group)
- unit Of Measure
- paarticipants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 39
- upper Limit
- 83
- value
- 59
- group Id
- BG001
- lower Limit
- 36
- upper Limit
- 79
- value
- 60.5
- group Id
- BG002
- lower Limit
- 36
- upper Limit
- 83
- value
- 60
- description
- BFI scale: 9 items; range=0-90 (0-10 per item) Mild = 1-3 Moderate = 4-7 Severe = 8-10
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Fatigue (baseline)-Brief Fatigue Inventory (BFI)
- unit Of Measure
- units on a scale
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 6
- upper Limit
- 12
- value
- 9
- group Id
- BG001
- lower Limit
- 6
- upper Limit
- 12
- value
- 9
- group Id
- BG002
- lower Limit
- 6
- upper Limit
- 12
- value
- 9
- description
- ICD-10 Criteria (Range: 0-14) A1-A11 Fatigue Criteria B. Clinically significant distress or impaired functioning C. Symptoms are a consequence of cancer or cancer therapy D. Symptoms are a consequence of comorbid psychiatric disorders
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Fatigue (baseline)-International Classification of Diseases version 10 (ICD-10)
- unit Of Measure
- units on a scale
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle